Walgreens (WAG) December Comps Up 2.6%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mail
Walgreens (NYSE: WAG) said December sale rose 7.8% to $5.51 billion. Sales in comparable stores rose 2.6%.
December pharmacy sales increased 8.4%, while comparable pharmacy sales increased 3.3%. Comparable pharmacy sales were negatively impacted by 4.4% points due to generic drug introductions in the last 12 months.
Comparable store front-end sales increased 1.7 percent during December.
December pharmacy sales increased 8.4%, while comparable pharmacy sales increased 3.3%. Comparable pharmacy sales were negatively impacted by 4.4% points due to generic drug introductions in the last 12 months.
Comparable store front-end sales increased 1.7 percent during December.
You May Also Be Interested In
- AT&T executive to retire as company sells Mexico wireless unit
- Taiwan To Curb Ai Chip Exports To China As Part Of U.S. Deal - Bloomberg
- Box, Inc. (BOX) PT Raised to Street High $50 at BofA Securities, New Top Pick, 'underappreciated AI winner'
Create E-mail Alert Related Categories
Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
